If this time frame of pharmacokinetics and the edema dynamics after cerebral infarction with the onset immediately after ischemia are taken into account, an even earlier time of application of EPO could possibly have led to a more pronounced neuroprotective effect. This evidence concerns the gene EPO and ischemia.